Who Exports Artemether from India — 481 Suppliers Behind a $897.9M Market
India's artemether export market is supplied by 481 active exporters who collectively shipped $897.9M across 8,652 shipments. IPCA LABORATORIES LIMITED leads with a 69.9% market share, followed by MACLEODS PHARMACEUTICALS LTD and INNOVA CAPTAB LIMITED. The top 5 suppliers together control 82.2% of total export value, reflecting a concentrated market structure.
Top Artemether Exporters from India — Ranked by Export Value
IPCA LABORATORIES LIMITED is the leading artemether exporter from India, holding a 69.9% share of the $897.9M market across 8,652 shipments from 481 exporters. The top 5 suppliers — IPCA LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, INNOVA CAPTAB LIMITED, MYLAN LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED — collectively control 82.2% of total export value, indicating a highly concentrated market. Individual shares are: IPCA LABORATORIES LIMITED (69.9%), MACLEODS PHARMACEUTICALS LTD (5.4%), INNOVA CAPTAB LIMITED (2.8%), MYLAN LABORATORIES LIMITED (2.3%), STRIDES PHARMA SCIENCE LIMITED (1.8%).
Top Artemether Exporters from India
Ranked by export value · 481 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $627.8M | 47 | 69.9% |
| 2 | MACLEODS PHARMACEUTICALS LTD ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $48.5M | 53 | 5.4% |
| 3 | INNOVA CAPTAB LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINEKUARTEM TABLETS 20/120 ARTEMETHER 20MG & | $24.9M | 5 | 2.8% |
| 4 | MYLAN LABORATORIES LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $20.3M | 22 | 2.3% |
| 5 | STRIDES PHARMA SCIENCE LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $16.2M | 26 | 1.8% |
| 6 | AFROWAY PHARMA ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINEKUARTEM TABLETS 20/120 ARTEMETHER 20MG & | $16.2M | 3 | 1.8% |
| 7 | AJANTA PHARMA LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $15.1M | 27 | 1.7% |
| 8 | S K AGE EXPORTS ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $9.1M | 16 | 1.0% |
| 9 | S KANT HEALTHCARE LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $8.4M | 9 | 0.9% |
| 10 | SURMOUNT LABORATORIES PRIVATE LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINEKUARTEM TABLETS 20/120 ARTEMETHER 20MG & | $8.4M | 8 | 0.9% |
| 11 | SANJEEVANI BIO-TECH EXIM PRIVATE LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINEKUARTEM TABLETS 20/120 ARTEMETHER 20MG & | $6.7M | 2 | 0.7% |
| 12 | MACLEODS PHARMACEUTICALS LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINELUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26 | $6.3M | 22 | 0.7% |
| 13 | LINCOLN PHARMACEUTICALS LTD ARTEMETHER 20MG + LUMEFANTRINE 120MG TABARTEMETHER 20MG+LUMEFANTRINE 120MG TABLEHARMLESS MEDICINE-ARTEMETHER 20MG + LUME | $5.0M | 7 | 0.6% |
| 14 | BIOMATRIX HEALTHCARE PRIVATE LIMITED LUMITER DT PS: 30X12SBNO:NAD2345D MD.02/23 ED.01/26ARTEMETHER 20MG + LUMEFANTRINE 120MG TABARTEMETHER AND LUMEFANTRINE TABLETS PH. | $4.7M | 5 | 0.5% |
| 15 | CIPLA LIMITED ARTEMETHER 20MG AND LUMEFANTRINE 120MG TABLETSTEMTRIN ( ARTEMETHER 20MG & LUMEFANTRINEKUARTEM TABLETS 20/120 ARTEMETHER 20MG & | $3.9M | 15 | 0.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Artemether exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| IPCA LABORATORIES LIMITED | Not Listed | Yes, as of April 25, | No | Not verified | WHO prequalified Pyrimethamine/Sulfadoxine tablets on April 25, 2024. (extranet. |
| MACLEODS PHARMACEUTICALS LTD | Not Listed | Yes, as of May 29, 2 | No | Not verified | WHO prequalified Artesunate powder for injection on May 29, 2024. (extranet.who. |
| MYLAN LABORATORIES LIMITED | Not Listed | Yes, as of May 23, 2 | No | Not verified | WHO prequalified Molnupiravir capsules on May 23, 2024. (extranet.who.int) |
| STRIDES PHARMA SCIENCE LIMITED | Not Listed | Yes, as of October 2 | No | Not verified | WHO prequalified Oseltamivir capsules on October 25, 2010. (extranet.who.int) |
| AJANTA PHARMA LIMITED | Not Listed | No | No | Not verified | No WHO prequalified products found. |
| S KANT HEALTHCARE LIMITED | Not Listed | Yes, as of May 2, 20 | No | Not verified | WHO prequalified Pyrimethamine/Sulfadoxine tablets on May 2, 2024. (extranet.who |
| CIPLA LIMITED | Not Listed | Yes, as of April 8, | No | Not verified | WHO prequalified Amodiaquine/Artesunate tablets on April 8, 2014. (extranet.who. |
TransData Nexus reviewed the regulatory standing of 7 leading Artemether exporters from India. 0 hold US FDA facility approvals, 6 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Artemether sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts numerous pharmaceutical companies specializing in the production of Active Pharmaceutical Ingredients (APIs). This cluster's robust infrastructure and skilled workforce make it a pivotal hub for API manufacturing, including Artemether. The presence of leading firms in this region underscores its significance in the global pharmaceutical supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies in this region excel in producing finished dosage forms, leveraging advanced manufacturing facilities and a favorable regulatory environment. This area contributes significantly to the formulation and export of Artemether-based products, catering to international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. With its strategic coastal location and well-developed port facilities, this region facilitates the efficient export of Artemether to global destinations. The concentration of pharmaceutical companies here ensures streamlined logistics and compliance with international quality standards.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives and supportive government policies. This region attracts numerous pharmaceutical companies, contributing to the production and export of various drugs, including Artemether.
5Sourcing Recommendations
- Diversify Supplier Base: While IPCA Laboratories Limited dominates Artemether exports, consider engaging with other significant suppliers such as Macleods Pharmaceuticals Ltd and Innova Captab Limited to mitigate supply chain risks.
- Leverage Regional Strengths: Utilize the specialized capabilities of different pharmaceutical clusters—Hyderabad for APIs, Ahmedabad-Vadodara for formulations, and Mumbai-Thane-Raigad for export logistics—to optimize sourcing strategies.
- Monitor Regulatory Compliance: Ensure that selected suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and facilitate smooth market entry.
- Assess Export Destinations: Given the concentration of Artemether exports to African nations, evaluate market demands and regulatory landscapes in these regions to align sourcing decisions with market opportunities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Artemether exporters from India
Ipca Laboratories Limited — Ipca Laboratories receives WHO prequalification for Artemether production
In November 2024, Ipca Laboratories Limited was granted prequalification status by the World Health Organization (WHO) for its Artemether production facilities. This certification confirms that Ipca's manufacturing processes meet international quality standards for Artemether production.
Impact: This prequalification is expected to enhance Ipca's credibility and potentially increase its Artemether exports to WHO member countries.
Macleods Pharmaceuticals Ltd — Macleods Pharmaceuticals secures FDA approval for Artemether injection
In March 2025, Macleods Pharmaceuticals Ltd received approval from the U.S. Food and Drug Administration (FDA) for its Artemether injection product. This approval allows Macleods to market and distribute its Artemether injection in the United States.
Impact: The FDA approval opens new market opportunities for Macleods, potentially increasing its Artemether export volumes.
Strides Pharma Science Limited — Strides Pharma Science receives EMA approval for Artemether tablets
In July 2025, Strides Pharma Science Limited obtained approval from the European Medicines Agency (EMA) for its Artemether tablet formulation. This approval permits Strides to market its Artemether tablets across European Union member states.
Impact: The EMA approval is likely to boost Strides' Artemether exports to European markets.
Common Questions — Artemether Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which artemether supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, IPCA LABORATORIES LIMITED leads with 600 recorded shipments worth $627.8M. MACLEODS PHARMACEUTICALS LTD (510 shipments) and INNOVA CAPTAB LIMITED (324 shipments) are also established high-volume exporters.
Q How many artemether manufacturers are there in India?
India has 481 active artemether exporters with a combined export market of $897.9M across 8,652 shipments to 107 countries. The top 5 suppliers hold 82.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for artemether from India?
Average FOB unit price: $8.41 per unit, ranging from $0.00 to $5735.20. Average shipment value: $103.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 481 verified Indian exporters of Artemether ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 8,652 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 107 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,652 Verified Shipments
481 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists